As of 2025-07-19, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -4.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 67.09 mil USD. CTSO's TTM EBITDA according to its financial statements is -13.73 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 23.3x | 21.6x |
| Forward P/E multiples | 22.1x - 22.7x | 22.4x |
| Fair Price | (4.88) - (5.02) | (4.86) |
| Upside | -573.6% - -587.6% | -572.3% |
| Date | EV/EBITDA |
| 2025-07-16 | -4.93 |
| 2025-07-15 | -4.89 |
| 2025-07-14 | -4.98 |
| 2025-07-11 | -5.02 |
| 2025-07-10 | -5.39 |
| 2025-07-09 | -5.25 |
| 2025-07-08 | -4.98 |
| 2025-07-07 | -4.89 |
| 2025-07-03 | -5.16 |
| 2025-07-02 | -4.75 |
| 2025-07-01 | -6.07 |
| 2025-06-30 | -6.03 |
| 2025-06-27 | -5.80 |
| 2025-06-26 | -5.57 |
| 2025-06-25 | -5.66 |
| 2025-06-24 | -5.66 |
| 2025-06-23 | -5.94 |
| 2025-06-20 | -5.57 |
| 2025-06-18 | -5.48 |
| 2025-06-17 | -5.66 |
| 2025-06-16 | -5.75 |
| 2025-06-13 | -5.16 |
| 2025-06-12 | -5.07 |
| 2025-06-11 | -5.16 |
| 2025-06-10 | -5.02 |
| 2025-06-09 | -5.12 |
| 2025-06-06 | -5.02 |
| 2025-06-05 | -4.98 |
| 2025-06-04 | -4.75 |
| 2025-06-03 | -4.75 |
| 2025-06-02 | -4.10 |
| 2025-05-30 | -4.02 |
| 2025-05-29 | -3.93 |
| 2025-05-28 | -4.02 |
| 2025-05-27 | -3.93 |
| 2025-05-23 | -4.04 |
| 2025-05-22 | -4.06 |
| 2025-05-21 | -4.16 |
| 2025-05-20 | -4.02 |
| 2025-05-19 | -4.07 |
| 2025-05-16 | -4.29 |
| 2025-05-15 | -4.00 |
| 2025-05-14 | -3.88 |
| 2025-05-13 | -4.16 |
| 2025-05-12 | -4.16 |
| 2025-05-09 | -4.16 |
| 2025-05-08 | -4.16 |
| 2025-05-07 | -4.22 |
| 2025-05-06 | -4.25 |
| 2025-05-05 | -4.33 |